Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, presenting steady, high-purity supplies for aging and cancer study. every day laboratory workflows frequently reveal a persistent challenge: the gradual and inefficient removing of senescent cells that impair tissue purpo